KEYNOTE-100: Final Results From Phase II Study on Pembrolizumab Monotherapy for Advanced Recurrent Ovarian Cancer

Jubilee Brown, MD, and Ursula Matulonis, MD, discuss current challenges in the management of endometrial and ovarian cancer, from Clinical Care Options (CCO)

Jubilee Brown, MD Ursula Matulonis, MD Released: May 3, 2021

From Clinical Care Options (CCO), webcast and downloadable slides on the use of PARP inhibitors to treat ovarian cancer, with Italian subtitles

Alexandra Leary, MD, PhD Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci Frederik Marmé, MD, PhD Released: April 29, 2021

From Clinical Care Options (CCO), webcast and downloadable slides on the use of PARP inhibitors to treat ovarian cancer, with Spanish subtitles

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci
Program Director Alexandra Leary, MD, PhD Frederik Marmé, MD, PhD Released: April 29, 2021

From Clinical Care Options (CCO), webcast and downloadable slides on the use of PARP inhibitors to treat ovarian cancer, with French subtitles

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci
Program Director Alexandra Leary, MD, PhD Frederik Marmé, MD, PhD Released: April 28, 2021